Macrophages and polymorphonuclear neutrophils in lung defense and injury

Medicine & Life Sciences

• Lung Injury 100%
• Neutrophils 74%
• Macrophages 66%
• Phagocytes 61%
• Alveolar Macrophages 56%
• Lung 39%
• Peptide Hydrolases 24%
• Oxidants 15%
• Respiratory System 13%
• Reactive Oxygen Species 11%
• Endothelial Cells 10%
• Epithelial Cells 10%
• Lymphocytes 10%
• Chronic Granulomatous Disease 9%
• Leukocyte Elastase 9%
• Cytokines 9%
• Respiratory Burst 8%
• Idiopathic Pulmonary Fibrosis 8%
• Lymphokines 8%
• Muramidase 8%
• Macrophage Activation 8%
• Chemotactic Factors 8%
• Emphysema 8%
• Hydroxyl Radical 8%
• Interstitial Lung Diseases 8%
• Leukopenia 7%
• Protease Inhibitors 7%
• Non-Smokers 7%
• Phagocytosis 7%
• Eosinophils 7%
• Infections 6%
• Endothelium 6%
• In Vitro Techniques 6%
• Blood Platelets 5%
• Fibroblasts 5%
• Antioxidants 5%
• Animal Models 5%
• Oxygen 5%
• Ligands 5%
• Blood Vessels 4%
• Enzymes 3%
• Growth 3%
• Animals 3%
• Wounds and Injuries 3%
• Serum 3%
• Neoplasms 2%